Use in Pregnancy - Category A: The benefits of asthma control outweigh any potential for an adverse pregnancy outcome.
Results from a large prospective epidemiological study and from world-wide post marketing experience indicate that inhaled budesonide during pregnancy has no adverse effects on the health of the foetus or new born child.
Inhaled glucocorticosteroids, such as budesonide, should be considered because of the lower systemic effects of doses, compared to those of oral glucocorticosteroids, required to achieve similar pulmonary responses.
Use in Lactation: Budesonide is excreted in breast milk. However, due to the relatively low doses used via the inhalational route the amount of drug present in the breast milk, if any, is likely to be low. Breastfeeding can be considered if the potential benefit outweighs any potential risks.